Keywords: sanofi-synthelabo, sales, climb, driven, blockbusters, french, drugmaker
Sanofi-Synthelabo sales climb 15.4%, driven by three blockbusters
Article | 29 April 2002
French drugmaker Sanofi-Synthelabo reports that its first-quarter 2002sales reached 1.86 billion euros ($1.64 billion), an increase of 15.4% on a comparable basis and 19.5% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
